A detailed history of Yousif Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Yousif Capital Management, LLC holds 257,535 shares of ABBV stock, worth $45.2 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
257,535
Previous 261,966 1.69%
Holding current value
$45.2 Million
Previous $44.9 Million 13.19%
% of portfolio
0.57%
Previous 0.52%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$163.84 - $199.33 $725,975 - $883,231
-4,431 Reduced 1.69%
257,535 $50.9 Million
Q2 2024

Jul 31, 2024

SELL
$154.79 - $180.76 $814,969 - $951,701
-5,265 Reduced 1.97%
261,966 $44.9 Million
Q1 2024

Apr 26, 2024

SELL
$159.82 - $182.1 $699,212 - $796,687
-4,375 Reduced 1.61%
267,231 $48.7 Million
Q4 2023

Feb 01, 2024

SELL
$137.6 - $154.97 $1.64 Million - $1.84 Million
-11,883 Reduced 4.19%
271,606 $42.1 Million
Q3 2023

Oct 30, 2023

SELL
$133.59 - $154.65 $671,556 - $777,425
-5,027 Reduced 1.74%
283,489 $42.3 Million
Q2 2023

Aug 02, 2023

BUY
$132.51 - $164.9 $272,838 - $339,529
2,059 Added 0.72%
288,516 $38.9 Million
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $1.94 Million - $2.23 Million
-13,401 Reduced 4.47%
286,457 $45.7 Million
Q4 2022

Jan 09, 2023

BUY
$138.31 - $165.87 $521,013 - $624,832
3,767 Added 1.27%
299,858 $0
Q3 2022

Nov 04, 2022

SELL
$134.21 - $153.93 $345,053 - $395,754
-2,571 Reduced 0.86%
296,091 $39.7 Million
Q2 2022

Aug 01, 2022

SELL
$137.62 - $174.96 $1.29 Million - $1.64 Million
-9,364 Reduced 3.04%
298,662 $45.7 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $488,062 - $605,547
3,698 Added 1.22%
308,026 $49.9 Million
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $32.7 Million - $41.4 Million
304,328 New
304,328 $41.2 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.